Home    Products    Sales Conditions & distributors    Quality controls    Instructions For Use    Links

#9650 Fasciola hepatica IgG ELISA (Trematoda)
ELISA kit for the diagnosis of human fascioliasis

Lot 2306D (Expiry date: 14.10.2024)

 

Production date : 15.02.2023

Results of quality control 2 (after 6 months), date: 14.08.2023

No serum blank (average) : 0.125

Sample

Absorbances of individual wells after blank reduction

Average

% pos.

No serum blank
-0.002 -0.002 0.005 -0.002 0.000 0
Negative control serum
(N° 965
0-06)
0.103 0.114 0.175 0.113 0.126 4
Weak positive serum
(N° 965
0-07)
0.469 0.492 0.488 0.485 0.483 17
Positive control serum
(N° 9650
-08)
2.708 2.980 2.701 2.967 2.839 100

Validation criteria:

  Criterion Measure Valid
Absorbance of positive serum 9650-08 > 1.200 2.839 Yes
Absorbance of weak positive serum 9650-07, as % of positive serum > 8 % 17 % Yes
Absorbance of negative serum 9650-06, as % of positive serum < 8 % 4 % Yes
Absorbance of no serum blank < 0.350 0.125 Yes

Comments:

Good for use.

Bordier Affinity Products SA, Chatanerie 2, Bātiment Biokema, CH-1023 Crissier, Switzerland
Phone: + 41 21 633 31 67.  Fax: + 41 21 633 31 78. Email: cb(at)bordier.ch